While this has been observed in melanoma, other studies found that CRC cells exhibit similar repression of CD8+ cytotoxic T cell trafficking to tumor sites, suggesting that the epigenetic silencing of immune pathways is a vital mechanism in CRC biology (10, 31). The gene discussed is CD8A; the disease is neoplasm.